159 related articles for article (PubMed ID: 33917976)
21. Comparison of the biophysical properties of racemic and d-erythro-N-acyl sphingomyelins.
Ramstedt B; Slotte JP
Biophys J; 1999 Sep; 77(3):1498-506. PubMed ID: 10465760
[TBL] [Abstract][Full Text] [Related]
22. Cholesterol modulation of sphingomyelinase activity at physiological temperatures.
Contreras FX; Sot J; Ruiz-Argüello MB; Alonso A; Goñi FM
Chem Phys Lipids; 2004 Jul; 130(2):127-34. PubMed ID: 15172829
[TBL] [Abstract][Full Text] [Related]
23. Using Alendronic Acid Coupled Fluorescently Labelled SM Liposomes as a Vehicle for Bone Targeting.
Medina OP; Medina TP; Humbert J; Qi B; Baum W; Will O; Damm T; Glüer C
Curr Pharm Des; 2020; 26(46):6021-6027. PubMed ID: 32534563
[TBL] [Abstract][Full Text] [Related]
24. Lipid-Iron Nanoparticle with a Cell Stress Release Mechanism Combined with a Local Alternating Magnetic Field Enables Site-Activated Drug Release.
Peñate Medina T; Gerle M; Humbert J; Chu H; Köpnick AL; Barkmann R; M Garamus V; Sanz B; Purcz N; Will O; Appold L; Damm T; Suojanen J; Arnold P; Lucius R; Willumeit-Römer R; Açil Y; Wiltfang J; Goya GF; Glüer CC; Peñate Medina O
Cancers (Basel); 2020 Dec; 12(12):. PubMed ID: 33327621
[TBL] [Abstract][Full Text] [Related]
25. An improved assay method for the measurement and detection of sphingomyelinase activity.
Taki T; Chatterjee S
Anal Biochem; 1995 Jan; 224(2):490-3. PubMed ID: 7733450
[TBL] [Abstract][Full Text] [Related]
26. Observation of topical catalysis by sphingomyelinase coupled to microspheres.
Nurminen TA; Holopainen JM; Zhao H; Kinnunen PK
J Am Chem Soc; 2002 Oct; 124(41):12129-34. PubMed ID: 12371852
[TBL] [Abstract][Full Text] [Related]
27. Fluorescence-based selection of gene-corrected hematopoietic stem and progenitor cells based on acid sphingomyelinase expression.
Schuchman EH; Erlich S; Miranda SR; Dinur T; Dagan A; Gatt S
Methods Enzymol; 2000; 312():330-8. PubMed ID: 11070882
[No Abstract] [Full Text] [Related]
28. Effect of saposins on acid sphingomyelinase.
Tayama M; Soeda S; Kishimoto Y; Martin BM; Callahan JW; Hiraiwa M; O'Brien JS
Biochem J; 1993 Mar; 290 ( Pt 2)(Pt 2):401-4. PubMed ID: 8452527
[TBL] [Abstract][Full Text] [Related]
29. Nuclear membrane sphingomyelin-cholesterol changes in rat liver after hepatectomy.
Albi E; Peloso I; Magni MV
Biochem Biophys Res Commun; 1999 Sep; 262(3):692-5. PubMed ID: 10471387
[TBL] [Abstract][Full Text] [Related]
30. Toward gene therapy for Niemann-Pick disease (NPD): separation of retrovirally corrected and noncorrected NPD fibroblasts using a novel fluorescent sphingomyelin.
Dinur T; Schuchman EH; Fibach E; Dagan A; Suchi M; Desnick RJ; Gatt S
Hum Gene Ther; 1992 Dec; 3(6):633-9. PubMed ID: 1482703
[TBL] [Abstract][Full Text] [Related]
31. Sphingomyelinase induces lipid microdomain formation in a fluid phosphatidylcholine/sphingomyelin membrane.
Holopainen JM; Subramanian M; Kinnunen PK
Biochemistry; 1998 Dec; 37(50):17562-70. PubMed ID: 9860872
[TBL] [Abstract][Full Text] [Related]
32. Sphingomyelinase treatment of low density lipoprotein and cultured cells results in enhanced processing of LDL which can be modulated by sphingomyelin.
Gupta AK; Rudney H
J Lipid Res; 1992 Dec; 33(12):1741-52. PubMed ID: 1479284
[TBL] [Abstract][Full Text] [Related]
33. Facile Method for Specifically Sensing Sphingomyelinase in Cells and Human Urine Based on a Ratiometric Fluorescent Nanoliposome Probe.
Zhang Y; Wu W; Zhang J; Li Z; Ma H; Zhao Z
Anal Chem; 2021 Aug; 93(34):11775-11784. PubMed ID: 34412477
[TBL] [Abstract][Full Text] [Related]
34. Upregulation of gene expression levels of ceramide metabolic enzymes after application of sphingomyelin-based liposomes to a three-dimensional cultured human epidermis model.
Itaya Y; Tokudome Y
Biochem Biophys Res Commun; 2016 Apr; 473(1):114-117. PubMed ID: 26995090
[TBL] [Abstract][Full Text] [Related]
35. Nature and mechanism of action of the CAMP protein of group B streptococci.
Bernheimer AW; Linder R; Avigad LS
Infect Immun; 1979 Mar; 23(3):838-44. PubMed ID: 378839
[TBL] [Abstract][Full Text] [Related]
36. Sphingomyelinase activity associated with human plasma low density lipoprotein.
Holopainen JM; Medina OP; Metso AJ; Kinnunen PK
J Biol Chem; 2000 Jun; 275(22):16484-9. PubMed ID: 10828058
[TBL] [Abstract][Full Text] [Related]
37. Acid sphingomyelinase as target of Lycium Chinense: promising new action for cell health.
Ceccarini MR; Codini M; Cataldi S; Vannini S; Lazzarini A; Floridi A; Moretti M; Villarini M; Fioretti B; Beccari T; Albi E
Lipids Health Dis; 2016 Oct; 15(1):183. PubMed ID: 27756324
[TBL] [Abstract][Full Text] [Related]
38. Synthesis of pyrenesulfonylamido-sphingomyelin and its use as substrate for determining sphingomyelinase activity and diagnosing Niemann-Pick disease.
Klar R; Levade T; Gatt S
Clin Chim Acta; 1988 Sep; 176(3):259-67. PubMed ID: 2846208
[TBL] [Abstract][Full Text] [Related]
39. Sphingomyelin Liposomes Containing Porphyrin-phospholipid for Irinotecan Chemophototherapy.
Carter KA; Luo D; Razi A; Geng J; Shao S; Ortega J; Lovell JF
Theranostics; 2016; 6(13):2329-2336. PubMed ID: 27877238
[TBL] [Abstract][Full Text] [Related]
40. Interaction of sphingomyelinase with sphingomyelin analogs modified at the C-1 and C-3 positions of the sphingosine backbone.
Lister MD; Ruan ZS; Bittman R
Biochim Biophys Acta; 1995 Apr; 1256(1):25-30. PubMed ID: 7742352
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
